Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans

Lu Liu(Shanghai Public Health Clinical Center), Jianqing Xu(Weifang Medical University), Lingyan Zhu(Shanghai Medical College of Fudan University), Raffael Nachbagauer(Moderna Therapeutics (United States)), Xinci Xie(Shanghai Medical College of Fudan University), Anli Zhang(Southwestern Medical Center), Florian Krammer(Semmelweis University), Zhaoguang Dong(Shanghai Public Health Clinical Center), Yanmin Wan(Shanghai Medical College of Fudan University), Ariana Hirsh(Icahn School of Medicine at Mount Sinai), Xiaoyan Zhang(Fujian Medical University), Xiaolin Shi, Shan Jin(Shanghai Medical College of Fudan University), Yang Huang(Fudan University), Songhua Yuan(Shanghai Medical College of Fudan University), Yunwen Hu(Southern University of Science and Technology), Di Tian(Shanghai Public Health Clinical Center)
The Journal of Infectious Diseases
February 15, 2017
10.1093/infdis/jiw608
Cited by 36

Related Papers

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
|Nature|2021|882
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713